Antonis Katsoulas, project leader of Innunity

Multiple sclerosis (MS) has been characterised for many years, not just as a disease, but as a syndrome. It affects different phases of the immune system from the brain to the spinal cord and the peripheral nervous system. Throughout the life of an MS patient, the disease has different phases.

The most common is the relapsing-remitting stage, usually followed by the secondary progressive stage of multiple sclerosis. Most of the drugs on the market target the relapsing-remitting stage to decrease the number of relapses, but there is a huge need to target the progressive stages when demyelination occurs. 

In this episode, we talk to Antonis Katsoulas, a PhD student at the University of Zurich who is leading the Innunity project investigating treatments for MS. He tells us about his journey juggling both entrepreneurship and his PhD studies, and how he hopes to make a real difference for later-stage MS patients.